EP3609471
FORMULATION OF (E)-2,4,6-TRIMETHOXYSTYRYL-3-[(CARBOXYMETHYL)AMINO]-4- METHOXYBENZYLSULPHONE WITH ENHANCED STABILITY AND BIOAVAILABILITY
:
EP einkaleyfi: Þýðing ekki lögð inn:
13.4.2018:
4.1.2023:
18718572.3
:
12.4.2038
:
FORMULATION OF (E)-2,4,6-TRIMETHOXYSTYRYL-3-[(CARBOXYMETHYL)AMINO]-4- METHOXYBENZYLSULPHONE WITH ENHANCED STABILITY AND BIOAVAILABILITY
13.4.2018
4.1.2023
:
Onconova Therapeutics, Inc.:
12 Penns Trail, Newtown, PA 18940, US
:
MANIAR, Manoj:
Fremont, CA 94539, US
:
201762485355 P:
13.4.2017:
US
:
201715688320:
28.8.2017:
US
:
PCT/US2017/048890:
28.8.2017:
WO
:
US2018027514:
13.4.2018
:
A61K 9/00, A61K 9/48, A61K 47/10, A61K 31/198, A61P 35/00, A61P 35/02